Schedule of Events
Wednesday, February 26, 2020
| 4:00 p.m. - 6:00 p.m. |
Registration |
Thursday, February 27, 2020
| 7:00 a.m. - 4:15 p.m. |
Registration |
| 7:00 a.m. - 8:00 a.m. |
Continental Breakfast |
| 7:55 a.m. - 8:00 a.m. |
Day One Welcome |
| 8:00 a.m. - 9:30 a.m. |
Oral Cavity
- Guidelines for Oral Cavity
- Surgery for Oral Cavity Carcinoma
- Radiation Oncology for Oral Cavity Carcinoma
- Systemic Therapy for Oral Cavity Cancer
- Questions and Answers
|
| 9:30 a.m. - 10:15 a.m. |
Keynote I: Cutting-edge Combinations with Radiation |
| 10:15 a.m. - 10:45 a.m. |
Coffee Break |
| 10:45 a.m. - 12:15 p.m. |
K. Kian Ang, MD, PhD, FASTRO, Commemorative Plenary Session |
| 12:15 p.m. - 1:15 p.m. |
Lunch
Expert Office Hours |
| 1:15 p.m. - 2:45 p.m. |
HPV-associated Tonsil and Base of Tongue Squamous Cell Carcinoma
- Guidelines for Tonsil and Base of Tongue
- Challenges in Deintensification of Radiation Therapy
- New Staging and How It Affects (or Could Affect) Therapy
- Adjuvant Therapy in HPV-associated Head and Neck Cancer
- HPV: Where do we go next?
- Question and Answers
|
| 2:45 p.m. - 3:15 p.m. |
Coffee Break |
| 3:15 p.m. - 4:15 p.m. |
Tumor Board: Early-stage Disease |
| 4:15 p.m. - 5:15 p.m. |
Poster Viewing Session and Reception |
Friday, February 28, 2020
| 7:00 a.m. - 5:30 p.m. |
Registration |
| 7:00 a.m. - 8:00 a.m. |
Continental Breakfast |
| 7:55 a.m. - 8:00 a.m. |
Day Two Welcome |
| 8:00 a.m. - 9:30 a.m. |
Larynx/Hypopharynx
- Guidelines for Larynx/Hypopharynx
- Surgical Approaches for Early Laryngeal Cancer
- Role of Induction
- Guidelines for Target Delineation
- Questions and Answers
|
| 9:30 a.m. - 10:15 a.m. |
Keynote II: Immune-related Therapies and Clinical Trial Updates |
| 10:15 a.m. - 10:45 a.m. |
Coffee Break |
| 10:45 a.m. - 12:15 p.m. |
Oral Abstract Session |
| 12:15 p.m. - 1:15 p.m. |
Lunch
Trainee and Early-career Networking Luncheon |
| 1:15 p.m. - 2:45 p.m. |
Rare Cancers of the Head and Neck
- Challenges in Salivary Gland and Sinonasal Neuroendocrine Pathology
- Salivary Gland Cancer
- Esthesioneuroblastoma
- Sinonasal Neuroendocrine and Undifferentiated Carcinomas
|
| 2:45 p.m. - 3:15 p.m. |
Coffee Break |
| 3:15 p.m. - 4:30 p.m. |
Breakout Session I: Advances in Molecular Imaging
- Intraoperative Molecular Imaging
- FDG-PET Update in Head and Neck Cancer
- Predicting Immunotherapy in Head and Neck Cancer
- Questions and Answers
Breakout Session II: Survivorship
- Financial Toxicity and Employment in Head and Neck Cancer Patients
- Vascular Disease in Head and Neck Cancer Survivorship
- Are Current PROs Adequate for Head and Neck Cancer Patients?
- Dental Evaluation in the Head and Neck Cancer Patient
- Questions and Answers
|
| 4:30 p.m. - 5:30 p.m. |
Tumor Board: Advanced Disease |
Saturday, February 29, 2020
| 7:00 a.m. - 12:15 p.m. |
Registration |
| 7:00 a.m. - 8:00 a.m. |
Continental Breakfast |
| 7:55 a.m. - 8:00 a.m. |
Welcome |
| 8:00 a.m. - 9:30 a.m. |
Advances in Immunotherapy
- Established and Emerging Biomarkers for Immunotherapy
- Combination Immunotherapy
- Role of Immunotherapy in Curative Intent
- Cellular Therapy
- Questions and Answers
|
| 9:30 a.m. - 10:15 a.m. |
De-escalation Debate |
| 10:15 a.m. - 10:45 a.m. |
Coffee Break |
| 10:45 a.m. - 12:15 p.m. |
Cutaneous Squamous Cell Carcinoma and Carcinoma of Unknown Primary
- Guidelines for Unknown Primary Management
- Pathology for Unknown Primary and How to Grade Perineural Invasion for Skin Cancer
- Radiation Oncology for Skin Cancer
- Systemic Treatment of Skin Cancer
- Questions and Answers
|
Copyright © 2019 American Society for Radiation Oncology | Conflict of Interest |
Terms of Use |
Privacy Policy |
Contact Us
251 18th Street South, 8th Floor, Arlington, VA 22202 | Phone: 703.502.1550 | Fax: 703.502.7852